Close Menu

This article has been updated with information from Roche's earnings call.

NEW YORK (GenomeWeb) – Roche today reported a 7 percent increase in sales of its diagnostics division in 2018, driven by high demand for immunodiagnostic solutions, which are part of its Centralized and Point of Care Solutions business.

Overall, Roche reported CHF 56.85 billion ($57.21 billion) in revenues for the year, up 7 percent from CHF 53.3 billion in 2017.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.